Literature DB >> 10531258

Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells.

C M Thorpe1, B P Hurley, L L Lincicome, M S Jacewicz, G T Keusch, D W Acheson.   

Abstract

In the 1980s, Shiga toxin (Stx)-producing Escherichia coli O157:H7 (STEC) was identified as a cause of hemorrhagic colitis in the United States and was found to be associated with hemolytic uremic syndrome (HUS), a microangiopathic hemolytic anemia characterized by thrombocytopenia and renal failure. The precise way that Stxs cause hemorrhagic colitis and HUS is unclear. Stxs have been thought to cause disease by killing or irreversibly harming sensitive cells through a nonspecific blockade of mRNA translation, eventually resulting in cytotoxicity by preventing synthesis of critical molecules needed to maintain cell integrity. Because STEC is noninvasive, we have been exploring the host-toxin response at the level of the gastrointestinal mucosa, where STEC infection begins. We have found that Stx is capable of interleukin-8 (IL-8) superinduction in a human colonic epithelial cell line. Despite a general blockade of mRNA translation, Stx treatment results in increased IL-8 mRNA as well as increased synthesis and secretion of IL-8 protein. Our data suggest that an active Stx A subunit is required for this activity. Ricin, which has the same enzymatic activity and trafficking pathway as Stx, has similar effects. Exploration of the effects of other protein synthesis inhibitors (cycloheximide, anisomycin) suggests a mechanism of gene regulation that is distinct from a general translational blockade. Use of the specific p38/RK inhibitor SB202190 showed that blocking of this pathway results in decreased Stx-mediated IL-8 secretion. Furthermore, Stxs induced mRNA of the primary response gene c-jun, which was subsequently partially blocked by SB202190. These data suggest a novel model of how Stxs contribute to disease, namely that Stxs may alter regulation of host cell processes in sensitive cells via activation of at least one member of the mitogen-activated protein kinase family in the p38/RK cascade and induction of c-jun mRNA. Stx-induced increases in chemokine synthesis from intestinal epithelial cells could be important in augmenting the host mucosal inflammatory response to STEC infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531258      PMCID: PMC96984     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned HeLa cells.

Authors:  M Jacewicz; H A Feldman; A Donohue-Rolfe; K A Balasubramanian; G T Keusch
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

2.  Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.

Authors:  P Angel; E A Allegretto; S T Okino; K Hattori; W J Boyle; T Hunter; M Karin
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

3.  Hemolytic-uremic syndrome. Clinical and pathological considerations.

Authors:  E Lieberman; E Heuser; G N Donnell; B H Landing; G D Hammond
Journal:  N Engl J Med       Date:  1966-08-04       Impact factor: 91.245

Review 4.  Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.

Authors:  P M Griffin; S M Ostroff; R V Tauxe; K D Greene; J G Wells; J H Lewis; P A Blake
Journal:  Ann Intern Med       Date:  1988-11-01       Impact factor: 25.391

5.  Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features.

Authors:  L Slutsker; A A Ries; K D Greene; J G Wells; L Hutwagner; P M Griffin
Journal:  Ann Intern Med       Date:  1997-04-01       Impact factor: 25.391

6.  Prevention and reversal of experimental colitis by a monoclonal antibody which inhibits leukocyte adherence.

Authors:  J L Wallace; A Higa; G W McKnight; D E MacIntyre
Journal:  Inflammation       Date:  1992-08       Impact factor: 4.092

Review 7.  Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites.

Authors:  M B Grisham; D N Granger
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

8.  The effect of enterohemorrhagic Escherichia coli O157:H7 on intestinal structure and solute transport in rabbits.

Authors:  Z Li; C Bell; A Buret; R Robins-Browne; D Stiel; E O'Loughlin
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: lack of evidence for labile repressors.

Authors:  D R Edwards; L C Mahadevan
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

View more
  70 in total

1.  Intestinal damage in enterohemorrhagic Escherichia coli infection.

Authors:  Zivile D Békássy; Carla Calderon Toledo; Gustav Leoj; Anncharlotte Kristoffersson; Shana R Leopold; Maria-Thereza Perez; Diana Karpman
Journal:  Pediatr Nephrol       Date:  2010-09-01       Impact factor: 3.714

2.  Shiga toxin 2 and flagellin from shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation.

Authors:  Dakshina M Jandhyala; Trisha J Rogers; Anne Kane; Adrienne W Paton; James C Paton; Cheleste M Thorpe
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

3.  Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides.

Authors:  Lisa M Harrison; Christel van den Hoogen; Wilhelmina C E van Haaften; Vernon L Tesh
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Outer membrane protein A of Escherichia coli O157:H7 stimulates dendritic cell activation.

Authors:  Alfredo G Torres; Yongguo Li; Christopher B Tutt; Lijun Xin; Tonyia Eaves-Pyles; Lynn Soong
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

5.  Toxicity of ricin A chain is reduced in mammalian cells by inhibiting its interaction with the ribosome.

Authors:  Amanda E Jetzt; Xiao-Ping Li; Nilgun E Tumer; Wendie S Cohick
Journal:  Toxicol Appl Pharmacol       Date:  2016-09-15       Impact factor: 4.219

6.  Subtilase cytotoxin activates PERK, IRE1 and ATF6 endoplasmic reticulum stress-signalling pathways.

Authors:  Jennifer J Wolfson; Kerrie L May; Cheleste M Thorpe; Dakshina M Jandhyala; James C Paton; Adrienne W Paton
Journal:  Cell Microbiol       Date:  2008-04-21       Impact factor: 3.715

Review 7.  Shiga toxins--from cell biology to biomedical applications.

Authors:  Ludger Johannes; Winfried Römer
Journal:  Nat Rev Microbiol       Date:  2009-12-21       Impact factor: 60.633

8.  Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway.

Authors:  Shaoguang Wu; Jan Powell; Nes Mathioudakis; Sheryl Kane; Ellen Fernandez; Cynthia L Sears
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  The hemorrhagic coli pilus (HCP) of Escherichia coli O157:H7 is an inducer of proinflammatory cytokine secretion in intestinal epithelial cells.

Authors:  Maria A Ledesma; Sara A Ochoa; Ariadnna Cruz; Luz M Rocha-Ramírez; Jaime Mas-Oliva; Carlos A Eslava; Jorge A Girón; Juan Xicohtencatl-Cortes
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

Review 10.  Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Ramon Alfonso Exeni; Romina Jimena Fernandez-Brando; Adriana Patricia Santiago; Gabriela Alejandra Fiorentino; Andrea Mariana Exeni; Maria Victoria Ramos; Marina Sandra Palermo
Journal:  Pediatr Nephrol       Date:  2018-01-25       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.